CRISPR's Limitations in Mitochondrial DNA Editing and Emerging Alternatives
CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in. CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are…
Read the full articleYou might also wanna read
Emerging therapeutic strategies for mitochondrial DNA-related primary mitochondrial diseases: a review of gene editing, heteroplasmy modulation, and transplantation approaches
In this review, Shi et al. discuss emerging therapeutic strategies for mitochondrial DNA-related primary mitochondrial diseases, including g
Precision gene editing technologies: From proof-of-concept to clinical therapies
Gene therapy is evolving from gene addition to precise genome editing, enabling the direct correction of disease-causing mutations. Breakthr
Deaf people excluded from gene-editing debate
There is no majority support for use of gene editing on non-life-threatening conditions, writes Tom Lichy of the British Deaf Association Yo
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics
This new technology could one day significantly expand the market for gene-editing biotechs.
Improved CRISPR base editing shows safer embryo gene editing, but major ethical questions remain
A team in the US has reported promising results after using an improved form of CRISPR to gene-edit human embryos, but a major issue remains
newscientist.com·1mo agoScaling CRISPR-Based Therapies: Overcoming Challenges in Development and Manufacturing
The post Scaling CRISPR-Based Therapies: Overcoming Challenges in Development and Manufacturing appeared first on Synthego .
Comments
Sign in to join the conversation.
No comments yet. Be the first.